NETrin MAbs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NETrin MAbs, covering 2024-10-08 to 2024-10-08. Get the full timeline:
Most recent: Clinical Trial Update: GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab [Phase 1, Phase 2]